Clinical Trials Browser

OTHER × Sarcoma × Dacarbazine × Clear all

NCT06835049 2025-12-30

TNT-HYPE

Phase 2 Recruiting

Hyperthermia, Sarcoma

NCT03805022 2025-10-02

CIRSARC

Phase 3 Recruiting

Sarcoma

NCT03277924 2024-08-13

ImmunoSarc

Phase 1/2 Completed

Chondrosarcoma, Extraskeletal Myxoid, Bone Neoplasms, Chondrosarcoma, Hemangioendothelioma, Hemangiosarcoma, Leiomyosarcoma, Sarcoma, Sarcoma, Ewing, Osteosarcoma, Sarcoma, Synovial, Sarcoma, Clear Cell, Sarcoma, Alveolar Soft Part, Hemangioendothelioma, Epithelioid, Histiocytoma, Malignant Fibrous, Solitary Fibrous Tumors

NCT00802880 2017-02-13

Dacarbazine for Metastatic Soft Tissue and Bone Sarcoma

Phase 2 Completed

80 enrolled 17 charts

Sarcoma

NCT00580320 2016-08-18

Safety Study of Dacarbazine and Bortezomib in Melanoma and Soft Tissue Sarcoma

Phase 1 Completed

DermatologicEndocrineHead & NeckSarcomaThoracic

Carcinoid Tumor, Melanoma, Parathyroid Neoplasms, Sarcoma, Small Cell Lung Carcinoma

NCT00837148 2015-11-20

Sorafenib and Dacarbazine in Soft Tissue Sarcoma

Phase 2 Completed

37 enrolled 6 charts

Leiomyosarcoma, Sarcoma, Sarcoma, Synovial, Neurofibrosarcoma